Keyphrases
Clinical High Risk
100%
Recent Advances
100%
Risk Stratification
100%
Serum Biomarkers
100%
Patient Management
100%
Cardio-oncology
100%
Radiation-induced Cardiotoxicity
100%
In Cancer
75%
Cancer Therapy
25%
Early Intervention
25%
Cancer Risk
25%
Meta-analysis
25%
Cancer-specific Survival
25%
MicroRNA
25%
Cancer Patients
25%
Galectin-3 (Gal-3)
25%
Protease Inhibitors
25%
Myeloperoxidase
25%
Cancer Therapeutics
25%
Cardiovascular Mortality
25%
Troponin
25%
Natriuretic Peptides
25%
Novel Biomarkers
25%
Patients at Risk
25%
Cancer Survivors
25%
Cardiac Biomarkers
25%
Cardiovascular Morbidity
25%
Monitoring Patients
25%
Surveillance Strategy
25%
Subclinical Disease
25%
Growth Differentiation factor-15 (GDF-15)
25%
Biomarker Strategy
25%
Cancer Care Continuum
25%
Risk Monitoring
25%
Medicine and Dentistry
Biological Marker
100%
Patient Care
100%
Oncology
100%
Risk Stratification
100%
Cancer Therapy
83%
Cardiotoxicity
66%
Malignant Neoplasm
50%
Cardiovascular System
16%
microRNA
16%
Meta-Analysis
16%
Galectin 3
16%
Early Intervention
16%
Myeloperoxidase
16%
Natriuretic Factor
16%
Proteasome Inhibitor
16%
Troponin
16%
Growth Differentiation Factor 15
16%
Patient Monitoring
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Biological Marker
100%
Cardiotoxicity
50%
Proteasome Inhibitor
12%
Galectin 3
12%
Myeloperoxidase
12%
Natriuretic Factor
12%
microRNA
12%
Troponin
12%
Growth Differentiation Factor 15
12%
Diseases
12%